
Eli Lilly Expands Research Footprint in Boston’s Seaport
Boston, October 23, 2025 News Summary Eli Lilly and Co. has signed a lease for 75,000 additional square feet at 645 Summer Street, now named Lilly
Stay informed on the latest developments in the pharmaceutical sector in Boston, MA, a hub for innovation and research. This news category page covers a wide range of topics including groundbreaking drug discoveries, clinical trials, regulatory updates, and partnerships between biotech firms and pharmaceutical companies. Read about the emerging trends in pharmaceuticals, advancements in personalized medicine, and the impact of local institutions such as Harvard and MIT on the industry. Stay updated on the efforts of Boston-based companies in tackling global health challenges and the role they play in shaping the future of healthcare.
Explore in-depth articles that delve into the pharmaceutical landscape in Boston, MA, featuring insights from industry experts, interviews with leading scientists, and analyses of market dynamics. From the latest FDA approvals to discussions on healthcare policy affecting pharmaceutical companies, this page serves as a comprehensive resource for professionals and enthusiasts alike. Discover the vibrant ecosystem of startups, established firms, and research institutions driving Boston’s reputation as a biotechnology capital. Engage with the latest news on funding rounds, drug launches, and collaborations that highlight Boston’s pivotal role in the global pharmaceutical industry.

Boston, October 23, 2025 News Summary Eli Lilly and Co. has signed a lease for 75,000 additional square feet at 645 Summer Street, now named Lilly

Boston, October 14, 2025 News Summary British biotech CellCentric is establishing a new office in Boston, marking a strategic move for its U.S. expansion. This facility

Massachusetts, October 11, 2025 News Summary Rite Aid has closed all its stores nationwide, marking a significant shift in retail pharmacy in Massachusetts where it had

Boston, October 10, 2025 News Summary Blue Cross Blue Shield of Massachusetts (BCBS) is providing voluntary buyouts to around 750 employees due to unprecedented financial losses.

Boston, October 9, 2025 News Summary Boston, the leading center of life sciences globally, is at risk as federal funding cuts and global competition increase. Proposed

Greater Boston, September 4, 2025 News Summary Despite a record-high vacancy rate of 33.9%, Greater Boston’s life sciences market is displaying resilience in early 2025. Leasing

News Summary Sage Therapeutics, a biotech company focusing on mental health treatments, will lay off 338 employees after being acquired by Supernus Pharmaceuticals. The layoffs,

News Summary Vertex Pharmaceuticals has announced the layoff of 125 employees in Rhode Island due to the discontinuation of its VX-264 program aimed at treating

News Summary Funding reductions in U.S. science and biotechnology sectors are significantly disrupting job opportunities for scientists. Proposed cuts for 2026 include a 40% reduction

News Summary Boston’s lab market is struggling with high vacancy rates despite nearly 1 million square feet of new lab space certified by the BPDA.